Belpointe Asset Management’s Nomura Holdings NMR Stock Holding History

Belpointe Asset Management’s Portfolio NMR Stock Details NMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-470	Closed	-$1.76K	–	3810
2022 Q4	$1.76K	Buy	+470	New	+$1.62K	﹤0.01%	3300

Other funds holding NMR

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ethic Inc New York $6.39B AUM 29.64% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Belpointe Asset Management's NMR Position: Q1 2023 in Review

Belpointe Asset Management sold out of Nomura Holdings (NMR) in Q1 2023, closing a stake of 470 shares — an estimated $1.76K sold.

Belpointe Asset Management first reported a position in NMR in Q4 2022 and held it in 1 quarter. The position peaked at $1.76K in Q4 2022. 121 funds tracked by Wall St. Rank hold NMR as of Q1 2023.

Belpointe Asset Management reported no remaining Nomura Holdings position as of Q1 2023 after selling out during the quarter.
Belpointe Asset Management sold 470 Nomura Holdings shares in Q1 2023, an estimated $1.76K.
Belpointe Asset Management first reported a position in Nomura Holdings in Q4 2022 and held it in 1 quarter.
Belpointe Asset Management's Nomura Holdings position peaked at $1.76K in Q4 2022.
121 funds tracked by Wall St. Rank held Nomura Holdings as of Q1 2023.

Based on Belpointe Asset Management's 13F filing for Q1 2023, filed 15 May 2023.